62 related articles for article (PubMed ID: 20952480)
1. Analysis of Risk Factors for Rheumatoid Arthritis in Yunnan: A Small-Scale Case-Control Study.
Li W; Sun Y
Comput Intell Neurosci; 2022; 2022():3948448. PubMed ID: 35785088
[TBL] [Abstract][Full Text] [Related]
2. New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies.
Dubois-Galopin F; Beauvillain C; Dubois D; Pillet A; Renier G; Jeannin P; Masson C; Chevailler A
Ann Rheum Dis; 2007 Aug; 66(8):1121-2. PubMed ID: 17626972
[No Abstract] [Full Text] [Related]
3. Does Changing Anticyclic Citrullinated Protein Testing From Restricted Ordering to Open Ordering Affect Healthcare Utilization and the Rate of Positive Testing?
Ramsay D; Taylor T
J Rheumatol; 2024 Apr; 51(4):432-433. PubMed ID: 38224982
[No Abstract] [Full Text] [Related]
4. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis.
Khudhair HAA
J Med Life; 2023 Aug; 16(8):1194-1200. PubMed ID: 38024817
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.
Wang XP; Cheng QY; Gu MM; Leng RX; Fan YG; Li BZ; Ye DQ
Clin Rheumatol; 2019 Jul; 38(7):1841-1849. PubMed ID: 30810911
[TBL] [Abstract][Full Text] [Related]
6. Anti-perinuclear Factor as Diagnostic Marker in Rheumatoid Arthritis.
Abedian Z; Sagafi M; Kenari SA; Abedian F
J Clin Diagn Res; 2015 Sep; 9(9):OC13-6. PubMed ID: 26500935
[TBL] [Abstract][Full Text] [Related]
7. Anti-microtubule organizing center with microtubule by autoimmune target test is also useful serological marker in rheumatoid arthritis evaluation.
Kim DA; Kim TY
Rheumatol Int; 2013 Mar; 33(3):805-8. PubMed ID: 22101553
[TBL] [Abstract][Full Text] [Related]
8. Bilateral recurrent wrist flexor tenosynovitis and rice body formation in a patient with sero-negative rheumatoid arthritis: A case report and review of literature.
Iyengar K; Manickavasagar T; Nadkarni J; Mansour P; Loh W
Int J Surg Case Rep; 2011; 2(7):208-11. PubMed ID: 22096729
[TBL] [Abstract][Full Text] [Related]
9. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
10. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
11. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?
Zhao J; Liu X; Wang Z; Liu R; Li Z
J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480
[TBL] [Abstract][Full Text] [Related]
12. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
14. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
[TBL] [Abstract][Full Text] [Related]
15. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
